Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Challenger Energy hails Saffron-2 well; SDCL placing

Thu, 02nd Sep 2021 21:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Challenger Energy Group PLC - oil and gas producer in the Caribbean - Considers development of the Saffron-2 well to be economically justified, based on current production rates. Work is underway to update the geological and reservoir model with the results of Saffron-2. Talks with Arena Investors LP over funding continue. Challenger is investigating farm-out options and reserve based lending options. Challenger does not expect to issue further convertible loan notes under the facility that expired in July.

----------

Premier African Minerals PLC - metals and rare earths miner - Encounters visible spodumene mineralisation at the Zulu lithium and tantalum project in Zimbabwe. First assay results from the project are expected this month, and a third rig is expected in October.

----------

Good Energy Group PLC - Chippenham-based renewable energy utility - Holders of 27% of shares have accepted Ecotricity Group Ltd's 340p-per-share takeover offer, including the 25% already owned by Ecotricity. The offer remains open for acceptance.

----------

Oracle Power PLC - coal miner in Pakistan and gold explorer in Western Australia - Receives conversion notice for a further GBP100,000 of the GBP1.5 million share subscription announced in July 2020. Oracle will issue 31.3 million shares. GBP400,000 remains outstanding for conversion under the subscription.

----------

Active Energy Group PLC - London-based biomass fuel producer - Results from an independent analysis show that Active Energy's CoalSwitch pellets are superior to white pellets, producing less ash, less carbon and more heat.

----------

Sensyne Health PLC - Oxford-based healthcare software developer - Signs five-year research agreement with Great Ormond Street Hospital in London to analyse anonymised patient data using clinical artificial intelligence. The agreement focuses on paediatric drug discovery, clinical decision support tools and clinical trial design.

----------

Hemogenyx Pharmaceuticals PLC - London-based blood disease drug developer - Patent application, titled "Monocloncal Antibodies to Human FLT3/FLK2 Receptor Protein", approved in the US. The patent is another important step in develping Hemogenyx's intellectual property and protecting its drug candidates, company says.

----------

Tiziana Life Sciences PLC - London-based cancer drug developer - Signs licence deal with Precision Biosciences Inc, a Durham, North Carolina-based company developing CAR T-cell therapies. The two companies will explore whether Tiziana's foralumab can improve the outcome of CAR T-cell therapy. "Precision will be responsible for the development, commercialization, and costs for use of foralumab, and Tiziana will receive upfront payment, certain milestone payments, and royalties," Tiziana says.

----------

SDCL Energy Efficiency Income Trust PLC - investor in energy infrastructure - Plans to issue 158.4 million shares at 110.5 pence each, a 6.0% discount to the Wednesday closing price, through an open offer, placing, offer for subscription and intermediaries offer. That would raise around GBP175 million. The money will be used to invest in a pipeline of opportunities worth over GBP200 million.

----------

Zephyr Energy PLC - oil and gas explorer in the Rocky Mountain region - Test results from the State 16-2LN-CC well in the Paradox Basin, Utah, provide strong evidence of the potential to develop the Cane Creek reservoir as a hydraulically stimulated resource play. Final well completion design work is underway and the company has secured equipment and a completion crew. Production testing will start in October and initial flow test results are expected by the end of that month.

----------

Goldstone Resources Ltd - gold explorer in Ghana, Senegal and Gabon - Deadline to pay interest on a loan from Asia Investments Management Services Ltd is further extended to September 19. Interest will continue to accrue at a 17% rate. Goldstone is in talks with AIMS to reschedule and restructure the loan.

----------

SolGold PLC - gold and copper explorer in Ecuador - Exploration drilling at the Rio Amarillo project is underway. Hole 1 returned encouraging surface rock-saw channel sample results. "The regional geological setting and gross geological architecture at Rio Amarillo is very impressive," Technical Services Manager Benn Whistler says.

----------

Empyrean Energy PLC - oil and gas explorer in China, Indonesia and California - Awards integrated drilling contract for the Jade prospect offshore China to China Oilfield Services Ltd. COSL's drilling cost estimate of USD12.3 million is lower than the previous estimate for USD18.5 million. Well spud date target set for December 15 to December 30.

----------

Supply@Me Capital PLC - London-based inventory monetisation services provider - Agrees a 12-month loan facility provided by ARC Group. The facility includes an initial tranche of GBP5 million, with a further GBP2 million available within 60 days, at an interest rate of 10%. Warrants will be issued for 20% of the total value. The facility will replace the subscription agreement with Negma Group Ltd, and the remaining GBP2.1 million in convertible bonds held by Negma will be repaid in cash. Supply@Me continues to explore a Nasdaq listing.

----------

Corcel PLC - battery metals explorer in Papua New Guinea - Extends the dates by which Resource Mining Corp Ltd has to repay its debt of AUD4.8 million, around GBP2.5 million. The first AUD2.8 million is now due on October 31 instead of September 30. The remainder continues to be due on January 14. This is to allow Resource Mining time to hold its general meeting, following Corcel's acquisition of the Wo Wo Gap nickel-cobalt project from Resource Mining. As consideration for the acquisition, Corcel is "releasing all liabilities and obligations" in connection with the debt.

----------

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Feb 2019 11:40

Tiziana Life Sciences Non-Exec Director Riccardo Dalla-Favera Resigns

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday said Non-Executive Director Riccardo Dalla-Favera has resigned from his role."The company is grateful to Favera for his

Read more
3 Dec 2018 14:27

Tiziana completes patient enrolment in ongoing Milciclib study

(Sharecast News) - Biotechnology company Tiziana Life Sciences announced on Monday that patient enrolment in its ongoing Phase 2a clinical trial, known as CDKO-125A-010, was now completed.

Read more
3 Dec 2018 11:51

Tiziana Life Completes Patient Enrollment In Liver Cancer Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday said it completed patient enrollment in a Phase 2a trial of Milciclib in hepatocellular carcinoma.The company explained that the

Read more
28 Nov 2018 12:19

Tiziana Life Sciences Begins First-In-Human Phase 1 Trial Of Foralumab

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it began the first in-human trial of Foralumab, a treatment for autoimmune diseases.The biotechnology company said the a

Read more
20 Nov 2018 12:53

Tiziana Life Sciences Prices ADS Offering, Raises GBP3.4 Million

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has priced its underwritten public offering in the US of 442,910 American Depositary Shares representing ordinary shares in

Read more
25 Sep 2018 13:43

Tiziana Life Seeks Listing Of ADS On Nasdaq Capital Market (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has commenced underwritten public offering in the US of American Depositary Shares representing ordinary shares in the UK of

Read more
24 Sep 2018 12:37

Tiziana Half-Year Loss Unchanged; Gets US Approval For Foralumab Trial

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday reported a flat loss in the first half of 2018 as expenses were broadly unchanged, while the biotechnology firm also announced that its

Read more
17 Aug 2018 11:39

DIRECTOR DEALINGS: Tiziana Life Chairman Associate Buys Shares

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth acquired 469,766 a

Read more
16 Aug 2018 11:47

Tiziana seeks trial for multiple sclerosis 'game changer'

(Sharecast News) - Tiziana Life Sciences on Thursday submitted an application to initiate phase one clinical trials for a new treatment of neurodegenerative diseases to the US food and drug administration.

Read more
27 Jul 2018 11:14

Tiziana Life Sciences Files For IPO Of American Depositary Shares (ALLIPO)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday it filed a registration statement with the US Securities Exchange Commission for a proposed initial public offering of its American

Read more
16 May 2018 13:27

Tiziana Life Science Reports Progress In Milcicib Phase 2a Trial

LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC said Wednesday that the phase 2a trial of Milciclib safety and tolerability in patients with Metastatic Hepatocellular has

Read more
19 Apr 2018 14:44

Tiziana Raises GBP825,000 Through Placing Of 1 Million Shares (ALLISS)

LONDON (Alliance News) - Tiziana Life Sciences PLC said Thursday it has raised GBP825,000 from the issue of 1.0 million new shares at a price of 80 pence per share.The cancer and autoimmune

Read more
4 Apr 2018 12:53

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined

Read more
16 Nov 2016 09:34

Tiziana Life Sciences makes breakthrough oral treatment for inflammatory diseases

(ShareCast News) - Tiziana Life Sciences, the clinical stage biotechnology company, announced that new data has demonstrated the potential of its novel oral therapy with foralumab for non-alcoholic steatohepatitis (NASH), diabetes and other life threatening inflammatory diseases. Oral efficacy in hu

Read more
18 Jul 2016 12:03

Tiziana Life looks for secrets of long life with new acquisition

(ShareCast News) - Tiziana Life Sciences has purchased key assets from Sardinia-based biobanking and genomics research company Shardna for €258,000, giving it access to the genetic data of nearly 13,000 people from the Ogliastra region, where life expectancy is high. The AIM-listed clinical stage bi

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.